These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Left ventricular deformation associated with cardiomyocyte Ca(2+) transients delay in early stage of low-dose of STZ and high-fat diet induced type 2 diabetic rats. Liu XY; Liu FC; Deng CY; Zhang MZ; Yang M; Xiao DZ; Lin QX; Cai ST; Kuang SJ; Chen J; Chen SX; Zhu JN; Yang H; Rao F; Fu YH; Yu XY BMC Cardiovasc Disord; 2016 Feb; 16():41. PubMed ID: 26879576 [TBL] [Abstract][Full Text] [Related]
6. Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options. Cieluch A; Uruska A; Zozulinska-Ziolkiewicz D Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325880 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic Cardiomyopathy. Ni R; Zheng D; Xiong S; Hill DJ; Sun T; Gardiner RB; Fan GC; Lu Y; Abel ED; Greer PA; Peng T Diabetes; 2016 Jan; 65(1):255-68. PubMed ID: 26470784 [TBL] [Abstract][Full Text] [Related]
9. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy. Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293 [TBL] [Abstract][Full Text] [Related]
10. Cell shortening and calcium dynamics in epicardial and endocardial myocytes from the left ventricle of Goto-Kakizaki type 2 diabetic rats. Smail M; Al Kury L; Qureshi MA; Shmygol A; Oz M; Singh J; Howarth FC Exp Physiol; 2018 Apr; 103(4):502-511. PubMed ID: 29363193 [TBL] [Abstract][Full Text] [Related]
11. Ca Jaquenod De Giusti C; Palomeque J; Mattiazzi A Pflugers Arch; 2022 Jan; 474(1):33-61. PubMed ID: 34978597 [TBL] [Abstract][Full Text] [Related]
12. Calcium handling in the failing heart and SUMO--weighing the evidence. McMurray JJ; Smith GL N Engl J Med; 2011 Nov; 365(18):1738-9. PubMed ID: 22047567 [No Abstract] [Full Text] [Related]
13. Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications. Kota SK; Kota SK; Jammula S; Panda S; Modi KD Diabetes Technol Ther; 2011 Nov; 13(11):1155-60. PubMed ID: 21751873 [TBL] [Abstract][Full Text] [Related]
14. Voltage dependence of the Ca Al Kury L; Sydorenko V; Smail MMA; Qureshi MA; Shmygol A; Oz M; Singh J; Howarth FC Mol Cell Biochem; 2018 Sep; 446(1-2):25-33. PubMed ID: 29318456 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Knapp M; Tu X; Wu R Acta Pharmacol Sin; 2019 Jan; 40(1):1-8. PubMed ID: 29867137 [TBL] [Abstract][Full Text] [Related]
16. The ins and outs of calcium in heart failure. O'Rourke B Circ Res; 2008 Jun; 102(11):1301-3. PubMed ID: 18535266 [No Abstract] [Full Text] [Related]
17. Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathy. Mishra PK; Givvimani S; Metreveli N; Tyagi SC Biochem Biophys Res Commun; 2010 Oct; 401(2):175-81. PubMed ID: 20836991 [TBL] [Abstract][Full Text] [Related]
18. Update on diabetic cardiomyopathy: inches forward, miles to go. Tillquist MN; Maddox TM Curr Diab Rep; 2012 Jun; 12(3):305-13. PubMed ID: 22528596 [TBL] [Abstract][Full Text] [Related]
19. Remodeling of excitation-contraction coupling in the heart: inhibition of sarcoplasmic reticulum Ca(2+) leak as a novel therapeutic approach. Neef S; Maier LS Curr Heart Fail Rep; 2007 Mar; 4(1):11-7. PubMed ID: 17386180 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy. Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]